For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Take a look at our BETA site and see what we’ve done so far.
Search and browse selected products
Purchase these through your usual distributor
Find out how to identify necroptosis, pyroptosis and ferroptosis.
Distinguishing between different forms of non-apoptotic cell death can be challenging, especially as many share similar morphological features. However, the distinct regulatory pathways involved with each provide distinct protein markers that can be used for their detection.
Whether you are looking at necroptosis, pyroptosis or ferroptosis, a combination of different approaches should be used. The study of non-apoptotic cell death should use both specific positive indicators of the cell death mode of interest, coupled with other cell viability assays and techniques to rule out apoptosis1.
Necroptosis is a programmed form of necrosis that is dependent on activation of receptor-interacting kinase 3 (RIPK3)2 and the mixed lineage kinase domain-like (MLKL) pseudokinase3. This form of cell death is morphologically distinct from apoptosis, involving membrane rupture and release of cytoplasmic contents.
Necroptosis is activated in response to death receptor activation, although some death receptor-independent pathways are also a trigger. In most contexts, necroptosis is inhibited by proapoptotic caspase 84–6; certain intracellular pathogens suppress apoptosis by inhibiting caspase 8, and necroptosis plays a role as a back-up to eliminate infected cells7.
The full necroptosis pathway can be found in our full Necroptosis analysis guide
Figure 1. The death receptor-dependent pathway of necroptosis
Although many proteins are involved in the necroptotic pathway, the most reliable method to detect necroptosis is by measuring the MLKL phosphorylation status and by specific inhibition of the necroptotic pathway.
|Protein||Role in necroptosis|
|RIPK1||Protein kinase that recruits RIPK3 to the necrosome, resulting in mutual phosphorylation of RIPK1 and RIPK3.|
|RIPK3||Protein kinase that phosphorylates MLKL8. Activated by phosphorylation by RIPK1 and subsequent oligomerization.|
|MLKL||Kinase domain-like protein. Once phosphorylated by RIPK3, MLKL translocates to the cell membrane to mediate cell death9.|
MLKL is activated by RIPK3-mediated phosphorylation. The activation state of MLKL can be determined by measuring the phosphorylation status of Thr357 and Ser358. Phospho-MLKL is detected by antibody-based methods, including western blot, IHC, and flow cytometry.
|Anti-MLKL (phospho S358) antibody (ab187091)|
Description: rabbit monoclonal
Application: IHC-P, WB
Image: staining human skin at 1/250 by IHC (FFPE)
Targeting components of the necroptotic pathway – either by chemical inhibition or with transgenic models – can be used to tell whether cell death is dependent on necroptosis.
Considerations when using inhibitors:
Pyroptosis is an inflammatory caspase-dependent form of programmed necrosis that occurs in response to microbial infection. Morphologically, pyroptotic cells display cell swelling and rapid plasma membrane lysis. Pyroptosis can be studied by looking at caspase activation, gasdermin D cleavage, or by inhibiting or ablating key components of the pyroptotic pathway.
|Protein||Function||Role in pyroptosis|
|Caspase 1||Inflammatory caspase, activated by sensor proteins and inflammatory agents||Cleaves gasdermin D|
|Caspase 11 (mouse) or|
Caspase 4 and 5 (human)
|Inflammatory caspases, activated by bacterial polysaccharides||Cleaves gasdermin D|
|Gasdermin D||Cleaved by caspases13–15||Executes pyroptosis|
Active caspases are cleaved from their inactive pro-caspase forms during pyroptosis. Caspase cleavage can be detected by western blot, using a specific caspase antibody.
|Anti-caspase 11 rabbit monoclonal antibody (ab180673)|
Description: rabbit monoclonal
Applications: western blot, IHC
Image: Antibody at 1/1000 dilution. Lane 1, untreated RAW 164.7 cell lysate. Lane 2, RAW 146.7 cells treated with lipopolysaccharide.
Although active caspases are cleaved, observing caspase cleavage alone is not proof of caspase activation, and other methods should also be used to confirm pyroptosis. Caspase activation can be detected directly using caspase activation assays.
|Caspase 1 assay kit (fluorometric, ab39412)|
Sample type: tissue extract, cell lysate
Assay time: 2 hours
Image: titration of caspase 1, background subtracted
Pyroptosis involves cleavage of gasdermin D (53 kDa), resulting in a 30 kDa N-terminal fragment, detected by western blot.
We recommend using our anti-gasdermin D rabbit polyclonal (ab155233), which detects the N-terminal region of gasdermin D.
Showing dependence on caspase 1, 11, 4 or 5 is essential to distinguish pyroptotic cell death from other forms of necroptosis and apoptosis. Determine if cell death still occurs after ablation of these caspases, either by chemical inhibition or using transgenic models.
Caspase 1 activity can be ablated by chemical inhibition with z-YVAD-fmk (ab141388).
Ferroptosis is an iron-dependent form of cell death that occurs as a consequence of lipid reactive oxygen species (ROS) production16. Cells undergoing ferroptosis exhibit subtle morphological features, including smaller-than-normal mitochondria with increased density. The presence of ferroptosis can be confirmed by looking at whether cell death is prevented by inhibitors, and by measuring lipid peroxides.
|Protein||Function||Role in ferroptosis|
|GPX4||Reduces lipid hydroperoxides within lipid membranes||Activity reduced in ferroptosis|
|Glutathione||Substrate for GPX4||Sometimes depleted in ferroptosis, depending on the molecular pathway|
The presence of ferroptosis can be confirmed using chemical inhibitors known to prevent ferroptosis. As ferroptosis is caused by reduction of GPX4 activity, knockdown is not an effective method.
Ferroptosis inhibitors and their modes of action:
|Inhibitor||Mode of action|
|Ferrostatin-1||Lipid peroxide scavenger|
|Liproxstatin-1||Unknown. Possibly reduction of free radicals|
Ferroptosis is dependent on lipid reactive oxygen species (ROS) accumulation. A number of methods are available to detect the presence of lipid ROS.
Methods to detect the presence of lipid ROS
|Assay||Mechanism||How to measure|
|C11-BODIPY||Detects free radical-induced oxidation||Quantification by flow cytometry|
|Malondialdehyde quantification||Malondialdehyde is a biproduct of lipid peroxidation||Lipid peroxidation (MDA) assay kit|
|4-HNE quantification||4-HNE is a biproduct of lipid peroxidation||Antibody-based quantification|
|Glutathione peroxidase assay kit (colorimetric, ab102530)|
Sample type: cell culture supernatant, urine, serum, plasma, platelets, tissue extracts
Sensitivity: 0.5 mU/mL
Image: Glutathione peroxidase activity measured in cell lysates. Data are per million cells after a 10-minute incubation
2. Moriwaki, K. & Chan, F. K. M. RIP3: A molecular switch for necrosis and inflammation. Genes Dev. 27, 1640–1649 (2013).
3. Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213–227 (2012).
4. Donnell, M. A. O. et al. NIH Public Access. 13, 1437–1442 (2012).
5. Lin, Y., Devin, A., Rodriguez, Y. & Liu, Z. G. Cleavage of the death domain kinase RIP by Caspase-8 prompts TNF-induced apoptosis. Genes Dev 13, 2514–2526 (1999).
6. Feng, S. et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 19, 2056–2067 (2007).
7. Mocarski, E. S., Guo, H. & Kaiser, W. J. Necroptosis: The Trojan horse in cell autonomous antiviral host defense. Virology 479–480, 160–166 (2015).